Development and Validation of a New Questionnaire for Caregivers to Assess Hip Pain in Quadriplegic Pediatric Patients: Non-Ambulatory Hip Pain Questionnaire

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-20
SponsorAzienda USL Reggio Emilia - IRCCS

About this trial

The goal of this clinical trial is twofold:

1. to develop a questionnaire for care givers to assess hip pain in quadriplegic pediatric patients who are not able to communicate it independently 2. to validate this questionnaire in a cohort of 100 pediatric patients with quadriplegia

Researchers will :

1. involve 10 experts (8 multiprofessional clinicians and 2 parents) in a Delphi approach to develop the questionnaire 2. assess construct validity and reliability of the questionnaire submitting it to 100 care givers of pediatric patients with quadriplegia, and comparing results with the Revised Face Legs Activity Cry and Consolability (r-FLACC) Scale assessed by the physiatrist during the visit

Participants will:

1. as experts, firstly answer open questions on this topic, secondly evaluate each item of the new questionnaire by means of a 5-point Liekert scale 2. as caregivers of pediatric patients with quadriplegia, fill out the questionnaire within 2 weeks after the visit

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

GMFCS IV-V

CFCS III-V

subscription of consent

Disqualifiers

care givers not speaking Italian or English

Trial design

Design model

Single group

Treatments tested in this trial

  • Non-Ambulatory Hip Pain questionnaire

    Diagnostic test

    a new questionnaire for care givers to identify hip pain in pediatric patients with quadriplegia

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: patients with quadriplegiaExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Content validity of the Non-Ambulatory Hip Pain questionnaire (NAHPq)

The questionnaire developed by means of the Delphi Method will be submitted to a group of 8-10 experts. They will evaluate each item and attribute one of the following judgments "essential", "usefull but not essential" or "unnecessary". The content validity ratio (CVR) for each item and the overall content validity index (CVI) will be calculated. The CVI is expected to be \> 0.75 for eight-expert group or \> 0.62 for 10-expert group. In case of lower values the items with the lowest CVR values will require to be revised, considering the experts' comments. The minimum and maximum values of the NAHPq are to be defined during the development Delphi phase; higher values will represent higher pain.

Time frame
The NAHPq is filled out by the caregiver within 2 weeks after the recruitment visit, during which the hip pain is assessed by the physiatrist with the r-FLACC scale.
2

Internal reliability of the Non-Ambulatory Hip Pain questionnaire (NAHPq)

After validity assessment, the questionnaire will be submitted to 100 caregivers of quadriplegic non-communicative patients aged 1-20 years. The Pearson's coefficient will be used to assess the inter-item correlation and the item-to-total correlation. The Cronbach's alpha will be calculated to measure the internal consistency.

Time frame
The NAHPq is filled out by the caregiver within 2 weeks after the recruitment visit, during which the hip pain is assessed by the physiatrist with the r-FLACC scale.

Secondary outcomes

1

Criterion validity of the Non-Ambulatory Hip Pain questionnaire (NAHPq)

Measure of the degree of reproducibility of the pain assessment with the questionnaire completed by the families compared to the clinical assessment of pain performed by the clinician during the visit by means of the Revised Face Legs Activity Cry and Consolability (r-FLACC) Scale (minimum value 0, maximum value 10; higher scores mean a worse outcome). The agreement between the NAHPq and the FLACC scale will be measured by means of Cohen's kappa coefficient or another correlation coefficient.

Time frame
The hip pain will be assessed by the physiatrist with the r-FLACC scale during the visit; by the care giver with the NAHPq within 2 weeks after the visit.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Azienda USL Reggio Emilia - IRCCS

Lead sponsor

IRCCS Fondazione Stella Maris

Collaborator